Boundless Bio, Inc. - Common Stock (BOLD)
1.4400
-0.0600 (-4.00%)
NASDAQ · Last Trade: May 10th, 8:25 PM EDT

BOLD stock results show that Boundless Bio beat analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 12, 2024

Boundless Bio just reported results for the first quarter of 2024.
Via InvestorPlace · May 13, 2024

Shares of Boundless Bio fell almost 10% after raising about $100 million in the company's initial public offering. Bayer is one of the biggest investors for the therapeutics company.
Via Talk Markets · March 31, 2024